Todd A Johnson Selected Research

Todd A Johnson Research Topics

4	Neoplasms (Cancer) 12/2023 - 12/2015
1	Kidney Neoplasms (Kidney Cancer) 12/2023
1	Carcinogenesis 12/2023
1	Chronic Renal Insufficiency 12/2023
1	Adenocarcinoma of Lung 01/2023
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 05/2021
1	Parkinson Disease (Parkinson's Disease) 08/2020
1	Heart Failure 01/2019
1	Fever (Fevers) 01/2018
1	Dysmenorrhea (Menstrual Pain) 01/2018
1	Endometriosis 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Aneurysm (Aneurysms) 12/2016
1	Uveal melanoma 12/2015
1	Melanoma (Melanoma, Malignant) 12/2015
1	Mesothelioma 12/2015
1	Disease Progression 09/2007
1	Experimental Arthritis 09/2007

4	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	Mitochondrial DNA (mtDNA)IBA 12/2023
1	LigandsIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	PlatinumIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 05/2021
1	HypoxanthineIBA 08/2020
1	Inosine FDA Link 08/2020
1	Adenosine Triphosphate (ATP)IBA 08/2020
1	Febuxostat FDA Link 08/2020
1	AMP Deaminase (Myoadenylate Deaminase)IBA 01/2019
1	HLA-DQA2 antigenIBA 01/2018
1	HLA-DRB1*04 antigenIBA 01/2018
1	EpitopesIBA 01/2018
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	Collagen Type II (Type II Collagen)IBA 09/2007

1	Neoadjuvant Therapy 01/2022
1	Therapeutics 12/2015